{"name":"Nile Therapeutics","slug":"nile-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":84454595,"netIncome":-105043946,"cash":355949294,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"date":"2026-03-17","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-10","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxONXZoSGZWeU5tR3doSWtkRHRkeGtxdVM1UnFJalU2MklpZU1LVnlyemVlM2RwTGxhRi1MY0xub1ZsRlBhVG5DVkRXSWkyLWswWFhJRHJTR2c1NjA3ZFJtTHJtOTcwME03dVdJUXdyU2pfMVh1a2FTN2VhT1JsMXI0eHkxczl0eE5aUlBzMUVXbkhUSTlSNlc3YW1YWURfcV91SVF3cnlsOG8?oc=5","date":"2026-02-04","type":"pipeline","source":"The Pharma Letter","summary":"BARDA launches $100M competition to spur antivirals innovation - The Pharma Letter","headline":"BARDA launches $100M competition to spur antivirals innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQckhwVjQySjNQbDhuR21IeGt0M3FLWmFWT2tVMGVaOXQ3RlM5LUtvU2VyOS1zbzc0WXRraFdqSnJsU3NRcUFaaDA5eDVCa21qMFZHUGI0N1NjQnQ4QVhFQkFKbnB0bHR4S2hrc1lGZU1iRlhPZzBFMGxmNU9JUFl4Vl9heWZxZXBsbXVDTDFqWWRCd1ZL?oc=5","date":"2026-01-10","type":"pipeline","source":"Seeking Alpha","summary":"Capricor Therapeutics: A High Risk/High Reward Name - Seeking Alpha","headline":"Capricor Therapeutics: A High Risk/High Reward Name","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxQZGN2aTZvRGRDdi1BcEp3NDhvMzhERmxUTVl3ZENfNTVILUY2TzZtTGpzejd5MmdBV2VVbTJrc1dTSGlVWGRpSGV5SUFHV0JvX3pneGFBN19PMC13U0Q1MDhxYXpPWnFVREN1TUd6ZEkwQzJudFdHUDNxZVU0elZlMGVFQ2FzYm9wOUxzYnM3NUQwYmQ1Rk45RHE3RmlFenQ2czk3TGFTUVl0OU1xTjFOUlIxNGZpbjR0VXo1bjdiV3pfdjFQRjVXb1dhcHlJRm9MRFFlbW1VQjA1aEowRWdBSUl0OUV3VF9ZRTFWVUhVaVFFVUY3M2I0?oc=5","date":"2025-12-01","type":"trial","source":"Stocktwits","summary":"Capricor Therapeutics Stock Sparks Retail Frenzy As Traders Hail ‘Best Data’ Ahead Of DMD Data Readout - Stocktwits","headline":"Capricor Therapeutics Stock Sparks Retail Frenzy As Traders Hail ‘Best Data’ Ahead Of DMD Data Readout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE8zRU50dWNSOGFaeTQweW9KY2dlQTJ0RXNiTDlfY09Dcm5SVHdZOGNCQUNJZEJtSGViTDNGWFNJSDQzMmZMUVJPdW01OFZtbnY0R0JB?oc=5","date":"2025-09-25","type":"regulatory","source":"FirstWord Pharma","summary":"Capricor sees FDA 'clarity' on path for DMD cell therapy after surprise rejection - FirstWord Pharma","headline":"Capricor sees FDA 'clarity' on path for DMD cell therapy after surprise rejection","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQTEFJaUdWSUJ5MUJ2dEIxNlMtbV9LdTRnNWpReHVMeUdxQTJQMHUwY295MGRPUzZGUVJpSjNHZW01d1luQ3VOSHhyS2hRODBkaVdpQkJ6RnJUbThMeVRSc253dEtCenByOHozMHRBSUNJSjVZazVzUnI1dy0zVDFyaHpOYXdfbkhJT05fQVZtdm4wazY0NUhLaUNCTFFOVEpOVmVuSkhsa0V4UjROVTZv?oc=5","date":"2025-08-20","type":"regulatory","source":"BioSpace","summary":"With Prasad Back at FDA, Capricor To Fight DMD Cardiomyopathy Rejection - BioSpace","headline":"With Prasad Back at FDA, Capricor To Fight DMD Cardiomyopathy Rejection","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQRXZhd3FmMnRzM1lEenpoY2M0R2lCTE55ZTBtVWlwNlhkVnl0dWRfS2FUNFc3QUlXb3dsYkRLQ0JuTG1xbUd2NUJrNTNfRVpKTHpITk43Y0VkZDVlRlg0cDZwYkFLZ2lWWmZRcWY3X3lyRFNfS0JPWXI4cExUZHNCQy1Dd3ZnTzdwYklkMUhB?oc=5","date":"2025-07-02","type":"regulatory","source":"Fierce Pharma","summary":"Regulatory tracker: 5 years on, Rubraca turns accelerated prostate cancer nod into full FDA approval - Fierce Pharma","headline":"Regulatory tracker: 5 years on, Rubraca turns accelerated prostate cancer nod into full FDA approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQc2IyWExaTnc4dGRlZkVSTno4MTBlTDdfTGx4UHZvdW5xTXFqQVNDR2tZS3pxSkpfbGFYT0NxTGZaeXlOeFF3MHF2MWxpcnRoU0I5UnVobWU4VkMyWldpbDhQa0pQM3BidTFmb1AzMThMMU4xSm5aSmdyUUo3T0czcU9XeXNmQmMxUkJWZUprbVZZcmZOd2hBSEt6VlJRSDFxeEhFSnRUdmoxRWs?oc=5","date":"2025-05-23","type":"deal","source":"Seeking Alpha","summary":"Capricor Therapeutics’ Buy Thesis Ahead Of Deramiocel PDUFA Date (NASDAQ:CAPR) - Seeking Alpha","headline":"Capricor Therapeutics’ Buy Thesis Ahead Of Deramiocel PDUFA Date (NASDAQ:CAPR)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOMDFwMkZ3cHJmc3BieHdlYXduNkx3YVg0SGR0Nll5UjlYUzJUbEhja3Q0RjB0YU9HbEI5YmlEd0IxZl80VlhKRHhoNVJVOHlYdDNoRzBJVjZ3TjcyX012Q01TSHRUZV91cHlaTDBjVGZmYXUzMTF3QlBIUXg0V1hvbzJZMy05S2FSaTQ1dHp3UUI?oc=5","date":"2025-05-09","type":"trial","source":"pharmaphorum","summary":"AZ plots wider Imfinzi use in bladder cancer after trial win - pharmaphorum","headline":"AZ plots wider Imfinzi use in bladder cancer after trial win","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOd3UtQmUzRVJsZFBEZFdibXFlQTZhQVFJNHdUR3lZZW5VU05yc2hKLVF1MjJiQVRfMkVyOU5pMkRKMFV6c1FGbHo2cXVYQnpHQmdHSlBlOC16bXJjdTdBT1pZQnRpREpYWXNoWVNFaXhnZ3Z1Q29PV0dXVlZKaFdaLWM5bkxZdlBRX1FZNFJ4QmxTa2paVXVtTkdDZ09RbkVFSk41N3VpeGxIQjc0N05rX0d4RzFIVmhCR19MUEZR?oc=5","date":"2025-05-06","type":"regulatory","source":"Fierce Biotech","summary":"Capricor shares turn red as FDA plans deramiocel adcomm, likely the first under new commissioner - Fierce Biotech","headline":"Capricor shares turn red as FDA plans deramiocel adcomm, likely the first under new commissioner","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNTTVKZUxEMzhyQ1ozb1lpTEwwc1N1amt5VGxzV2NpNG5fcVpfNml0NDFMRkZYeHNPa1c3WXFtQVRBODVIcnRHenZYQUcydGpFQlRCankzZkVGa21KQzcwWnVPaXBIS1dqaGltWmR6MW05WjRkRVFGelZPTUxpeVlDSmRrVF9QMmN0RmZXcllhOFZOOXV6c3dGbGpDOXJtbU1WZk1yQXd6T3dhNTdrVV9BR3l2UlEzWXl3eWhVMHpSeWVFYUJ5eXVSdGtzNFVsNHZzVTJwUQ?oc=5","date":"2025-05-05","type":"regulatory","source":"Reuters","summary":"US FDA to convene expert panel for Capricor Therapeutics' DMD cell therapy - Reuters","headline":"US FDA to convene expert panel for Capricor Therapeutics' DMD cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNNDctc2ljSkFTbU5sSGJ1clVRZFM0UWtYVEhBektBZEdETENEZnBXdHBDWlNpX0xTbzhGV0ZFSUI3ZzN1S2xYUV9WcXFtck1oM1J1OHlTQS1EbTBxNWhRMnhLbHh1dHJMcmZSTFByWE9ocE9iU2hZTmdwdFdzeTFYaVVLb0FWUF9Gdm0wRV9R?oc=5","date":"2024-05-15","type":"pipeline","source":"Centers for Disease Control and Prevention | CDC (.gov)","summary":"West Nile Virus Disease Therapeutics: Review of the Literature - Centers for Disease Control and Prevention | CDC (.gov)","headline":"West Nile Virus Disease Therapeutics: Review of the Literature - Centers for Disease Control and Prevention | CDC (.gov)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE5mUDNfOEZyMFR0NzZYa0RYenNvMHFVeUM0YnhHZ3E0ZUZYRE9oMDJTenA2M1FiRDJvLTJkVzBuQ3EzRnNhelo0UjZZaUZscXM1?oc=5","date":"2024-03-26","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":0,"period":"2025-12-31"},{"value":22270465,"period":"2024-12-31"},{"value":22270465,"period":"2024-12-31"},{"value":25178066,"period":"2023-12-31"},{"value":25178066,"period":"2023-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":84454595,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-105043946,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":355949294,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}